MBCL-30. SUBGROUP-DIRECTED CLINICAL AND MOLECULAR STRATIFICATION OF DISEASE RISK IN INFANT MEDULLOBLASTOMA

Understanding the specific molecular pathology of infant medulloblastoma (iMB) is urgently required to inform contemporary treatments, risk-stratification and clinical trials. Comprehensive analysis incorporating central clinical/ pathological review and molecular subgroup, copy number aberration an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Hicks, Debbie, Rafiee, Gholamreza, Schwalbe, Edward C, Lindsey, Janet C, Hill, Rebecca M, Smith, Amanda, Crosier, Stephen, Joshi, Abhijit, Robson, Keith, Wharton, Stephen, Jacques, Thomas, Williamson, Daniel, Bailey, Simon, Clifford, Steven C
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.426
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars